EP3101026
Efnasambönd til að hamla meltikornaensímum
Status:
EP Einkaleyfi útrunniðEP appl. date:
8.8.2005EP published:
28.3.2018EP application number:
16166492.5
EP translation filed:
21.6.2018Grant published:
15.7.2018EPO information:
European Patent Register
Max expiry date:
7.8.2025Expiry date:
7.8.2025
Title:
COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
Timeline
Today
8.8.2005EP application
28.3.2018EP Publication
21.6.2018Translation submitted
15.7.2018Registration published
7.8.2025Expires
Owner
Name:
Onyx Therapeutics, Inc.Address:
One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
Inventor
Name:
SMYTH, Mark S.Address:
San Mateso, CA, US
Name:
LAIDIG, Guy J.Address:
Menlo Park, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
599401 PDate:
6.8.2004Country:
US
Number:
610001 PDate:
14.9.2004Country:
US
Number:
106879Date:
14.4.2005Country:
US
Classification
Categories:
C07K 5/087
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 25.7.2018
Expires: 7.8.2019
Payer: Árnason Faktor
Number: 15
Paid: 9.7.2019
Expires: 7.8.2020
Payer: Árnason Faktor
Number: 16
Paid: 8.7.2020
Expires: 7.8.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 12.7.2021
Expires: 7.8.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 20.7.2022
Expires: 7.8.2023
Payer: Patice ehf.
Number: 19
Paid: 20.7.2023
Expires: 7.8.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 23.7.2024
Expires: 7.8.2025
Payer: Árnason Faktor ehf.